|1.||Wadhwa, Renu: 24 articles (07/2015 - 06/2003)|
|2.||Kaul, Sunil C: 23 articles (07/2015 - 06/2003)|
|3.||Deocaris, Custer C: 8 articles (01/2013 - 01/2005)|
|4.||Kaul, Zeenia: 7 articles (06/2015 - 12/2003)|
|5.||Yaguchi, Tomoko: 6 articles (09/2014 - 12/2003)|
|6.||Widodo, Nashi: 5 articles (03/2012 - 03/2007)|
|7.||Gao, Ran: 4 articles (06/2015 - 07/2010)|
|8.||Kaur, Kamaljit: 4 articles (07/2007 - 10/2005)|
|9.||Taira, Kazunari: 4 articles (10/2005 - 06/2003)|
|10.||Lu, Wen-Jing: 3 articles (07/2015 - 10/2011)|
11/01/2013 - "To the best of our knowledge, the study provides a first demonstration of transcellular crosstalk between stromal cells and BCCs that involve direct contact and may also include a transfer of mortalin, an anti-apoptotic and growth-promoting factor enriched in cancer cells. "
06/15/2006 - "The study demonstrates that upregulation of mortalin contributes significantly to tumorigenesis, and thus is a good candidate target for cancer therapy."
11/25/1997 - "We have performed immunohistochemical studies of mortalin in normal and tumor human brain sections. "
06/01/2015 - "Cancer cells when induced to senesce by either chemicals or stress showed shift in mortalin staining pattern from perinuclear to pancytoplasmic type. "
03/01/2015 - "Interestingly, mortalin depletion induced p21(CIP1) transcription not only in wild-type TP53 but also in TP53-mutated B-Raf(V600E) cancer cells, suggesting the presence of an additional mechanism for p21(CIP1) regulation. "
|2.||Ovarian Neoplasms (Ovarian Cancer)
08/09/2013 - "In this study, an assessment of mortalin expression using ovarian cancer tissue microarrays suggested that mortalin overexpression might be related to drug resistance. "
08/09/2013 - "Inhibition of mortalin expression reverses cisplatin resistance and attenuates growth of ovarian cancer cells."
08/09/2013 - "The results of our study show that elevated levels of mortalin expression increase cancer cell resistance to cisplatin-induced cytotoxicity and identify mortalin as a potential therapeutic target for improved treatment of drug-resistant ovarian cancer."
07/01/2014 - "In sporadic intestinal adenocarcinomas with strong p53 immunostaining (mutated TP53), ACSL5-related mortalin expression was heterogeneous. "
07/01/2014 - "TP53 status regulates ACSL5-induced expression of mitochondrial mortalin in enterocytes and colorectal adenocarcinomas."
01/01/2005 - "Using comparative proteomic analysis we have identified over-expression of mortalin in colorectal adenocarcinomas. "
01/01/2005 - "Mortalin is over-expressed by colorectal adenocarcinomas and correlates with poor survival."
06/29/2012 - "Since heatshock proteins like mortalin have been associated with p53 inactivation in other tumors, the current study sought to characterize this potential interaction in never before examined colorectal adenocarcinoma cell lines. "
|4.||Colorectal Neoplasms (Colorectal Cancer)
07/15/2013 - "Mortalin concentration in serum of colorectal cancer patients was 10-214 ng/ml. Survival data of the patients were known from an earlier study of sHSP70 in these samples. "
07/15/2013 - "Analysis of mortalin in blood, and even more so of mortalin and sHSP70, adds a high prognostic value to the TNM stage and will identify colorectal cancer patients at high risk of poor survival."
07/15/2013 - "The significance of mortalin in blood to survival prospects of colorectal cancer patients was evaluated. "
07/15/2013 - "Elevated levels of mitochondrial mortalin and cytosolic HSP70 in blood as risk factors in patients with colorectal cancer."
01/01/2005 - "Our findings demonstrate that mortalin over-expression may predict outcome in colorectal cancer and suggest that this protein is involved in colorectal neoplasia. "
|5.||Liver Neoplasms (Liver Cancer)
08/01/2011 - "Mortalin expression on the cultured liver cancer cells were characterized with immunocytochemistry, Real-time PCR, and western blot. "
08/01/2011 - "Expression of mortalin detected in human liver cancer by tissue microarrays."
08/01/2011 - "In this study, human tumor specimens from various organs of liver cancer at different stages and cultured liver cancer cells were used to study the expression pattern of mortalin. "
07/01/2015 - "We found that although mortalin is enriched in liver cancer cells and tumors, it is not detected in the serum of either the liver cirrhosis or cancer patients. "
02/01/2008 - "Association of mortalin (HSPA9) with liver cancer metastasis and prediction for early tumor recurrence."
|2.||Proteins (Proteins, Gene)
|7.||HSP70 Heat-Shock Proteins (Heat-Shock Protein 70)
|8.||Small Interfering RNA (siRNA)
|9.||Heat-Shock Proteins (Heat-Shock Protein)
|1.||Quantum Dots (Quantum Dot)
|2.||Heterologous Transplantation (Xenotransplantation)